Secukinumab shows high efficacy irrespective of HLA‐Cw6 status in patients with moderate‐to‐severe plaque‐type psoriasis: results from extension phase of the SUPREME study
暂无分享,去创建一个
K. Peris | A. Costanzo | G. Girolomoni | E. Aloisi | M. Romanelli | G. Stinco | A. Offidani | F. Cusano | C. Potenza | M. Papini | M. Burlando | M. Bartezaghi